| Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer DP Silver, AL Richardson, AC Eklund, ZC Wang, Z Szallasi, Q Li, N Juul, ... Journal of clinical oncology 28 (7), 1145-1153, 2010 | 1290 | 2010 |
| Impact of microplastics and nanoplastics on human health MSL Yee, LW Hii, CK Looi, WM Lim, SF Wong, YY Kok, BK Tan, CY Wong, ... Nanomaterials 11 (2), 496, 2021 | 678 | 2021 |
| p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis JW Rocco, CO Leong, N Kuperwasser, MP DeYoung, LW Ellisen Cancer cell 9 (1), 45-56, 2006 | 522 | 2006 |
| p63 regulates an adhesion programme and cell survival in epithelial cells DK Carroll, JS Carroll, CO Leong, F Cheng, M Brown, AA Mills, JS Brugge, ... Nature cell biology 8 (6), 551-561, 2006 | 495 | 2006 |
| E-cadherin: Its dysregulation in carcinogenesis and clinical implications SHM Wong, CM Fang, LH Chuah, CO Leong, SC Ngai Critical reviews in oncology/hematology 121, 11-22, 2018 | 430 | 2018 |
| The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers CO Leong, N Vidnovic, MP DeYoung, D Sgroi, LW Ellisen The Journal of clinical investigation 117 (5), 1370-1380, 2007 | 352 | 2007 |
| Mutant p53 mediates survival of breast cancer cells LY Lim, N Vidnovic, LW Ellisen, CO Leong British journal of cancer 101 (9), 1606-1612, 2009 | 229 | 2009 |
| Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers KH Tiong, LY Mah, CO Leong Apoptosis 18, 1447-1468, 2013 | 211 | 2013 |
| An evaluation of curcumin-encapsulated chitosan nanoparticles for transdermal delivery RS Nair, A Morris, N Billa, CO Leong Aaps Pharmscitech 20 (2), 69, 2019 | 177 | 2019 |
| Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment CK Looi, FFL Chung, CO Leong, SF Wong, R Rosli, CW Mai Journal of Experimental & Clinical Cancer Research 38, 1-23, 2019 | 168 | 2019 |
| Antitumour 2-(4-aminophenyl) benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo CO Leong, M Gaskell, EA Martin, RT Heydon, PB Farmer, MC Bibby, ... British journal of cancer 88 (3), 470-477, 2003 | 158 | 2003 |
| DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells V Trapani, V Patel, CO Leong, HP Ciolino, GC Yeh, C Hose, JB Trepel, ... British journal of cancer 88 (4), 599-605, 2003 | 150 | 2003 |
| HOXB13 promotes ovarian cancer progression J Miao, Z Wang, H Provencher, B Muir, S Dahiya, E Carney, CO Leong, ... Proceedings of the National Academy of Sciences 104 (43), 17093-17098, 2007 | 141 | 2007 |
| Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma MP DeYoung, CM Johannessen, CO Leong, W Faquin, JW Rocco, ... Cancer research 66 (19), 9362-9368, 2006 | 132 | 2006 |
| CYP2S1 and CYP2W1 Mediate 2-(3, 4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells BS Tan, KH Tiong, A Muruhadas, N Randhawa, HL Choo, TD Bradshaw, ... Molecular Cancer Therapeutics 10 (10), 1982-1992, 2011 | 122 | 2011 |
| In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazoles CO Leong, M Suggitt, DJ Swaine, MC Bibby, MFG Stevens, TD Bradshaw Molecular cancer therapeutics 3 (12), 1565-1575, 2004 | 121 | 2004 |
| Functional roles of JNK and p38 MAPK signaling in nasopharyngeal carcinoma LJW Pua, CW Mai, FFL Chung, ASB Khoo, CO Leong, WM Lim, LW Hii International journal of molecular sciences 23 (3), 1108, 2022 | 118 | 2022 |
| 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ) BS Tan, O Kang, CW Mai, KH Tiong, ASB Khoo, MR Pichika, ... Cancer letters 336 (1), 127-139, 2013 | 114 | 2013 |
| Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF) BS Tan, KH Tiong, HL Choo, F Fei-Lei Chung, LW Hii, SH Tan, IKS Yap, ... Cell death & disease 6 (7), e1826-e1826, 2015 | 112 | 2015 |
| Association of BRCA1-and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer WX Wen, CO Leong PLoS One 14 (4), e0215381, 2019 | 100 | 2019 |
Chun-Wai MaiProfessor, Institute for Research,Development and Innovation(IRDI), International Medical University確認したメール アドレス: imu.edu.my
